Latest News

Error loading HTML

Error loading HTML

Injectafer (ferric carboxymaltose) is an intravenous iron replacement medication prescribed to adult patients for the treatment of iron deficiency anemia. Research indicates that patients taking the iron replacement product are at high risk of developing hypophosphatemia (HPP), a condition that can be life-threatening. Injectafer lawsuits allege that consumers and the medical community were not adequately warned of Injectafer HPP risk and other adverse side effects.

Utah medical malpractice claims are essentially negligence claims made against doctors, hospitals or other healthcare professionals or organizations. They cover missteps like delaying treatment, giving the wrong medicine, using a defective medical device, failing to deliver a baby on time, or even just neglecting to give the patient enough information to make a reasonable medical decision. These are only a few of the reasons patients or their families may file Utah medical malpractice lawsuits.

Paragard IUD lawsuits are now in the early stages of multidistrict litigation (MDL) consolidation in Philadelphia and more lawsuits are under investigation. Melissa Arias’s story about her experience with her Paragard T 380A is sadly commonplace.

Settlement with Santander Includes more than $550 Million in Relief for Consumers

Elmiron (pentosan polysulfate sodium), a drug widely prescribed for a bladder condition, has been associated with eye damage. Hundreds of thousands of people who have taken Elmiron may have been exposed to the risk of potentially permanent vision damage. Recent studies suggest that Elmiron is toxic to the retina, and one study shows that about 25 percent of patients with significant exposure to the drug show signs of retinal damage. As a result of these studies, vision loss lawsuits have been filed against Janssen Pharmaceuticals for failing to properly warn the public about the risk of vision problems.

Since the CARES Act (also referred to as the Paycheck Protection Act, or “PPP”) rolled out on April 3, 2020, COVID-19-affected small businesses have claimed that banks processed loan applications to benefit themselves, rather than on the “first-come, first-served” basis, as the law requires. Defendants include Bank of America, JP Morgan Chase, U.S. Bank and Wells Fargo, among others.